DR. LOUIS VAICKUS, MD
Osteopathic Medicine at Franklin Rodgers Rd, Hingham, MA
License number
Massachusetts 176571-1
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
22 Franklin Rodgers Rd, Hingham, MA 02043
Phone
(781) 740-9028
Personal information
See more information about LOUIS VAICKUS at radaris.comName
Address
Phone
77 Rogers St, Quincy, MA 02169
22 Franklin Rodgers Rd, Hingham, MA 02043
864 Nantasket Ave, Hull, MA 02045
Professional information
Dr. Louis Vaickus, Hingham MA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
22 Franklin Rodgers Rd, Hingham 02043
(781) 740-9028 (Phone)
(781) 740-9028 (Phone)
Certifications:
Hematology, 1984, Internal Medicine, 1982, Medical Oncology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1977
Mayo Clinic-Rochester
Stanford University
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1977
Mayo Clinic-Rochester
Stanford University
Administration Of Anti-Cd3 Antibodies In The Treatment Of Autoimmune Diseases
US Patent:
2009025, Oct 15, 2009
Filed:
Jun 5, 2007
Appl. No.:
11/810235
Inventors:
Paul Ponath - San Francisco CA, US
Michael Rosenzweig - Boston MA, US
Louis Vaickus - Hingham MA, US
Michael Rosenzweig - Boston MA, US
Louis Vaickus - Hingham MA, US
International Classification:
A61K 39/395
US Classification:
4241301
Abstract:
A method of treating an autoimmune disease, such as, diabetes or psoriasis, by administering an anti-CD3 antibody, or anti-CD3 antibody fragment. The anti-CD3 antibody, or antibody fragment, is administered over a course of treatment wherein, during the course of treatment, the anti-CD3 antibody, or anti-CD3 antibody fragment is administered in a total amount which does not exceed 300 μg/kg when administered intravenously or, when administered other than intravenously, is administered in a total amount that does not exceed a total amount bioequivalent to 300 μg/kg of intravenous administration thereof.